Residual/recurrent disease and deaths at 6 years after open or robotic-assisted radical prostatectomy in the prospective, controlled trial LAPPRO von Nyberg, M.P., Akre, O., Bock, D., Carlsson, S.V., Carlsson, S., Hugosson, J., Steineck, G., Stranne, J., Tyritzis, S., Wiklund, P., Haglind, E., Bjartell, A.S.

Volltext

The impact of previous depression on the risk of suicide in prostate cancer patients von Friberg, A.S., Carlsson, S.V., Vickers, A.J., Dalton, S.O., Høeg, B.L., Saltbæk, L., Bidstrup, P.E., Brasso, K., Johansen, C., Benzon Larsen, S.

Volltext

Differences in contemporary biopsy Gleason score distribution in large cohorts of men diagnosed with prostate cancer from China and Canada von Dong, L., Xu, W., Woon, D., Kuk, C., Zhu, Y., Erlich, A., Ma, Z., Shi, O., Dong, B., Nesbitt, M., Carlsson, S.V., Kulkarni, G., Hamilton, R., Finelli, A., Fleshner, N.E., Toi, A., Van Der Kwast, T.H., Xue, W., Zlotta, A.R

Volltext

A0894 - Population-based organised prostate cancer testing: Outcomes of the first 999 men – a pilot project von Alterbeck, M., Jiborn, T., Carlsson, S.V., Thimansson, E., Bengtsson, J., Bjartell, A.

Volltext

Population-based organised prostate cancer testing: Outcomes of the first 999 men – a pilot project von Alterbeck, M., Jiborn, T., Carlsson, S.V., Thimansson, E., Bengtsson, J., Bjartell, A.

Volltext

A0255 - Patient reported outcomes after radical prostatectomy or radiotherapy for prostate cancer – register-based nationwide, population-based study von Corsini, C., Bergengren, O., Carlsson, S., Lissbrant, I.F., Garmo, H., Eriksson Hjelm, M., Kindblom, J., Westerberg, M., Robinson, D., Fransson, P., Stattin, P., Carlsson, S.V.

Volltext

Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data von Heijnsdijk, E A M, de Carvalho, T M, Auvinen, A, Zappa, M, Nelen, V, Kwiatkowski, M, Villers, A, Páez, A, Moss, S M, Tammela, T L J, Recker, F, Denis, L, Carlsson, S V, Wever, E M, Bangma, C H, Schröder, F H, Roobol, M J, Hugosson, J, de Koning, H J

Volltext

Patient reported outcomes after radical prostatectomy or radiotherapy for prostate cancer – register-based nationwide, population-based study von Corsini, C., Bergengren, O., Carlsson, S., Lissbrant, I.F., Garmo, H., Eriksson Hjelm, M., Kindblom, J., Westerberg, M., Robinson, D., Fransson, P., Stattin, P., Carlsson, S.V.

Volltext

The value of systematic biopsies in screening for prostate cancer with PSA followed by MRI – results from the GÖTEBORG prostate cancer screening 2 trial von Kohestani, K., Arnsrud Godtman, R., Axcrona, U., Egevad, L., Hellström, M., Khatami, A., Pihl, C-G., Stranne, J., Wallström, J., Månsson, M., Carlsson, S.V., Hugosson, J.

Volltext

88 Correlation between stage shift and differences in mortality between the two study arms of the ERSPC von Roobol, M.J, Auvinen, A, Carlsson, S.V, Kwiatkowski, M, Denis, L.J, Zappa, M, Paez, A, Hugosson, J, Moss, S.M, Bokhorst, L.P

Volltext

962 HOW SCREENING DOES AFFECT ERECTILE FUNCTION AND URINARY CONTINENCE FOLLOWING RADICAL PROSTATECTOMY: RESULTS FROM THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER... von Carlsson, S.V, Aus, G, Hugosson, J

Volltext

304 THE EFFECT OF AGE AND NUMBER OF SCREENING VISITS ON THE CUMULATIVE RISK OF PROSTATE CANCER. RESULTS FROM THE GOTHENBURG RANDOMISED SCREENING TRIAL von Godtman, R, Carlsson, S.V, Holmberg, E, Stranne, J, Hugosson, J

Volltext

1129 - The relation between baseline PSA, cancer detection and PC death, long-term data from ERSPC von Roobol, M., Remmers, S., Hugosson, J., Carlsson, S.V., Auvinen, A., Tammela, T.L.J., Denis, L.J., Nelen, V., Villers, A., Rebillard, X., Kwiatkowski, M., Recker, F., Zappa, M., Puliti, D., Paez, A., Lujan, M., Bangma, C.H.

Volltext

The relation between baseline PSA, cancer detection and PC death, long-term data from ERSPC von Roobol, M., Remmers, S., Hugosson, J., Carlsson, S.V., Auvinen, A., Tammela, T.L.J., Denis, L.J., Nelen, V., Villers, A., Rebillard, X., Kwiatkowski, M., Recker, F., Zappa, M., Puliti, D., Paez, A., Lujan, M., Bangma, C.H.

Volltext

Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy von Wu, X, Scott, H, Carlsson, S.V, Sjoberg, D.D, Cerundolo, L, Lilja, H, Prevo, R, Rieunier, G, Macaulay, V, Higgins, G.S, Verrill, C.L, Lamb, A.D, Cunliffe, V.T, Bountra, C, Hamdy, F.C, Bryant, R.J

Volltext bestellen